Galien Forum Logo
weeks
+
days
Galien_ForumUSA2026_white

Legacy & Leap: Hindsight, Foresight, and a Generation's Impact on Health Innovation

Thursday Oct. 29, 2026

  NEW VENUE  
NEW YORK ACADEMY OF MEDICINE
7:30 AM - 5 PM

Register now
Revisit the 2025 Edition

950

C-LEVEL PARTICIPANTS

125

COMPANIES

90

INSTITUTIONS/
ACADEMICS

* Based on 2025

Galien Forum
Galien Forum Logo
Galien Forum Logo

Thursday Oct. 26, 2023

Science Meets Society:

Balancing Innovation, Equity and Public Health in a Post-Covid World

Read the abstract
Mask Group 163

The Galien Forum, hosted this year at the New York Academy of Medicine, provides an entire day of lively discussions featuring Nobel Laureates, prominent policymakers, and top industry leaders who share insights on the most pressing health issues of our era, while showcasing the newest research and clinical approaches to diagnosis, treatment, and cure.

In tandem with the Forum, the second annual Galien Patient Summit will bring together patient groups, key thought leaders, regulators and industry to evaluate challenges through the patient prism.

Don’t miss the debates!

Forum 2025 room

In the program Galien Forum 2023

Thursday Oct. 26, 2023

Preliminary Program

PANEL 1

Breakthroughs & Blind Spots:
What Will Today’s Consensus Regret Tomorrow?

PANEL 2

Medical Triumph vs Pricing Paradox:
Can We Afford the Medicines We’re Capable of Creating?

PANEL 3

20 Years in 20 Minutes:
A History of Breakthroughs + Lessons for the Next 2 Decades

PANEL 4

The Biology We Still Don’t Understand:
Frontiers That Will Define the Next 20 Years

PANEL 5

Life Science Diplomacy & Scientific Sovereignty:
Strategy for the Next 20 Years

PANEL 6 I CEO PANEL

Biopharma Leaders:
Leading the Leap

FIRESIDE CHAT

FDA Commissioner
(1 Year Later)

PANEL 7

The Science Trust Conundrum:
When Society Doubts Its Own Progress

Galien Forum Logo
PANEL 1
Promise & Reality:
Decoding AI’s Impact on Drug Development
Galien Forum Logo

PANEL 2 
Advancing the Pipeline:
Ensuring Academic and Government Discoveries are Translated for Medical Impact

Mental Health in America
PANEL 3 
Therapeutic Area Advances and Challenges (mRNA & CRISPR): Getting Gene Therapy Innovation to a Critical Mass of Patients
Fireside with J&J’s Alex Gorsky
FIRESIDE CHAT 
Fireside Chat with Alex Gorsky
AI, Digital Health and Clinical Trials

PANEL 4a 
AI's Impact on Personal and Public Health -- Now & in the Future

PANEL OBESITY SCIENCE (1)

PANEL 4b 
Advancing Brain Health: Innovations and Insights for a Healthier Future

Fireside with J&J’s Alex Gorsky
CEO PANEL

How to Build a Paradigm-Transforming Blockbuster

Who will be speaking in 2026

Partial list as of March 23, 2026

Bruce Booth-1

Bruce Booth

Partner, Atlas Venture

Albert Bourla Photo

Albert Bourla

Chairman & CEO, Pfizer

Pr. Awa Marie COLL SECK, MD, PhD

Awa Coll Seck

Former Minister of Health, Senegal; Chair of Prix Galien Africa Committee

Howard Chang

Howard Chang

Senior Vice President, Global Research & CSO, Amgen

crowley_john

John F. Crowley

President & CEO, Biotechnology Innovation Organization (BIO)

Robert M. Davis-1 Image

Robert M. Davis

Chairman and CEO, Merck & Co., Inc
Sue Desmond-Hellmann

Sue Desmond-Hellman

Former CEO, Gates Foundation; Former Chancellor, UCSF

Samantha Du

Samantha Du

Co-founder & CEO, Zai Lab

Joaquin Duato

Joaquin Duato

Chairman & CEO, Johnson & Johnson

⁠Kenneth C. Frazier Image

Ken Frazier

Prix Galien USA Committee Chair; Retired Chairman & CEO, Merck & Co., Inc.; Chairman, Health Assurance Initiatives, General Catalyst

Yvonne Greenstreet

Yvonne Greenstreet

Chair & CEO, Alnylam

Atul A. Gawande

Atul A. Gawande

Fish Chair in Surgery, Brigham and Women’s Hospital; Samuel O. Thier Professor of the Practice, Harvard Medical School; Distinguished Professor in Residence, Ariadne Labs

Avram Hershko-1

Avram Hershko

Nobel Laureate, Distinguished Professor, The Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa

Katherine High

Katherine High

CEO, RhyGaze

Larry Jameson

Larry Jameson

President, University of Pennsylvania

Eric Lander

Eric Lander

Founding Director Emeritus & Core Institute Member, Broad Institute of MIT & Harvard

Olivier Laureau

Olivier Laureau

Chairman and CEO, Servier Group & Servier International Foundation for Research

Nick Leschly

Nick Leschly

Founder & CEO,  Atida Bio; Co-Founder & Chair, Altido Therapeutics; Former CEO, bluebird bio

Jeremy Levin

Jeremy Levin

Executive Chairman, Ovid Therapeutics; Former Chair, BIO

Brett Monia,

Brett Monia

CEO, Ionis Pharmaceuticals

Alex Oshmyansky

Alex Oshmyansky

CEO & Co-Founder, Mark Cuban Cost Plus Drug Company

Paulsen

Jean Frederic Paulsen

Chairman & CEO, Ferring Pharmaceuticals

Andrew Plump

Andrew Plump

President, Research & Development, Takeda

Vardit Ravitsky

Vardit Ravitsky

President and CEO, The Hastings Center for Bioethics

Michael Rosenblatt Photo

Michael Rosenblatt

Chair of Prix Galien USA Committee, Member, Harvard Board of Overseers

⁠Thomas Schinecker Photo

Thomas Schinecker

Chairman & CEO, Roche

⁠Marc Tessier-Lavigne Photo

Marc Tessier-Lavigne

CEO, Xaira Therapeutics; President Emeritus, Stanford

 

Helen Torley

Helen Torley

President & CEO, Halozyme Therapeutics

Renee Wegrzyn

Renee Wegrzyn

CEO, Transfyr (Former ARPA-H Director)

Xiaowei Zhuang

Xiaowei Zhuang

Howard Hughes Medical Institute; David B. Arnold Jr. Professor of Science; Professor of Chemistry, Chemical Biology & Physics, Harvard University

See who spoke in the 2022 edition
Register for the 2023 edition
Group 705

TOP SCIENTISTS & KOL

Interested in seeing who has spoken at our events? Check out our impressive roster of Top Scientists and Key Opinion Leaders.

PAST SPEAKERS
Group 721

PREVIOUS DEBATES

Watch continuous debates on the biggest challenges facing human health worldwide

WATCH THE DEBATES